Group A1 (16) | Group B (85) | Group A2 (33) | P | |
---|---|---|---|---|
Age (mean) | 40 | 66 | 0.001 | |
Symptoms | 100% | 62% | 0.031 | |
Extended surgery* | 43.7%*** | 9,4% | 0.032 | |
Proximal localization** | 43,7% | 34,1% | 0.46 | |
Mucinous | 56.2% | 14,1% | 0.047 | |
Advanced stage (T3-4) | 75% | 36,4% | 0.0042 | |
Undifferentiated | 31,2% | 9,4% | 0.0167 | |
Disease free survival (mean) | 63,9 m | 81 m | 0.057 | |
Overall survival (mean) | 64,5 m | 89 m | 0.048 | |
Disease free survival (mean) | 63,9 m | 78,2 m | 0.061 | |
Overall survival (mean) | 64,5 m | 81,6 m | 0.049 |